Format
Sort by
Items per page

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 184

1.

Clinical outcomes with the STENTYS Self-Apposing coronary stent in patients presenting with ST-segment elevation myocardial infarction 2-year insights from the APPOSTION III (A Post-Market registry to assess the STENTYS self-exPanding COronary Stent In AcuTe MyocardIal InfarctiON) registry.

Lu H, Grundeken MJ, Vos NS, Ijsselmuiden AJ, van Geuns RJ, Wessely R, Dengler T, La Manna A, Silvain J, Montalescot G, Spaargaren R, Tijssen JG, Amoroso G, de Winter RJ, Koch KT.

EuroIntervention. 2017 Feb 14. pii: EIJ-D-16-00676. doi: 10.4244/EIJ-D-16-00676. [Epub ahead of print]

2.

Extended Thromboprophylaxis with Betrixaban in Acutely Ill Medical Patients.

Cohen AT, Harrington RA, Goldhaber SZ, Hull RD, Wiens BL, Gold A, Hernandez AF, Gibson CM; APEX Investigators.

N Engl J Med. 2016 Aug 11;375(6):534-44. doi: 10.1056/NEJMoa1601747. Epub 2016 May 27.

3.

Aliskiren, Enalapril, or Aliskiren and Enalapril in Heart Failure.

McMurray JJ, Krum H, Abraham WT, Dickstein K, Køber LV, Desai AS, Solomon SD, Greenlaw N, Ali MA, Chiang Y, Shao Q, Tarnesby G, Massie BM; ATMOSPHERE Committees Investigators.

N Engl J Med. 2016 Apr 21;374(16):1521-32. doi: 10.1056/NEJMoa1514859. Epub 2016 Apr 4.

4.

Effect of Pre-Hospital Ticagrelor During the First 24 h After Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction: The ATLANTIC-H²⁴ Analysis.

Montalescot G, van 't Hof AW, Bolognese L, Cantor WJ, Cequier A, Chettibi M, Collet JP, Goodman SG, Hammett CJ, Huber K, Janzon M, Lapostolle F, Lassen JF, Licour M, Merkely B, Salhi N, Silvain J, Storey RF, Ten Berg JM, Tsatsaris A, Zeymer U, Vicaut E, Hamm CW; ATLANTIC Investigators.

JACC Cardiovasc Interv. 2016 Apr 11;9(7):646-56. doi: 10.1016/j.jcin.2015.12.024. Epub 2016 Mar 5.

5.

Stable or improved neurological manifestations during miglustat therapy in patients from the international disease registry for Niemann-Pick disease type C: an observational cohort study.

Patterson MC, Mengel E, Vanier MT, Schwierin B, Muller A, Cornelisse P, Pineda M; NPC Registry investigators.

Orphanet J Rare Dis. 2015 May 28;10:65. doi: 10.1186/s13023-015-0284-z.

6.

One-year clinical outcomes of the STENTYS Self-Apposing¨ coronary stent in patients presenting with ST-segment elevation myocardial infarction: results from the APPOSITION III registry.

Koch KT, Grundeken MJ, Vos NS, IJsselmuiden AJ, van Geuns RJ, Wessely R, Dengler T, La Manna A, Silvain J, Montalescot G, Spaargaren R, Tijssen JG, Amoroso G.

EuroIntervention. 2015 Jul;11(3):264-71. doi: 10.4244/EIJY15M02_08.

7.

IL-17A influences essential functions of the monocyte/macrophage lineage and is involved in advanced murine and human atherosclerosis.

Erbel C, Akhavanpoor M, Okuyucu D, Wangler S, Dietz A, Zhao L, Stellos K, Little KM, Lasitschka F, Doesch A, Hakimi M, Dengler TJ, Giese T, Blessing E, Katus HA, Gleissner CA.

J Immunol. 2014 Nov 1;193(9):4344-55. doi: 10.4049/jimmunol.1400181. Epub 2014 Sep 26.

8.

Prehospital ticagrelor in ST-segment elevation myocardial infarction.

Montalescot G, van 't Hof AW, Lapostolle F, Silvain J, Lassen JF, Bolognese L, Cantor WJ, Cequier A, Chettibi M, Goodman SG, Hammett CJ, Huber K, Janzon M, Merkely B, Storey RF, Zeymer U, Stibbe O, Ecollan P, Heutz WM, Swahn E, Collet JP, Willems FF, Baradat C, Licour M, Tsatsaris A, Vicaut E, Hamm CW; ATLANTIC Investigators.

N Engl J Med. 2014 Sep 11;371(11):1016-27. doi: 10.1056/NEJMoa1407024. Epub 2014 Sep 1.

9.

Inhibition of B7-1 (CD80) by RhuDex® reduces lipopolysaccharide-mediated inflammation in human atherosclerotic lesions.

Doesch AO, Zhao L, Gleissner CA, Akhavanpoor M, Rohde D, Okuyucu D, Hakimi M, Dengler TJ, Katus HA, Erbel C.

Drug Des Devel Ther. 2014 May 12;8:447-57. doi: 10.2147/DDDT.S59594. eCollection 2014.

10.

Safety of mid-septal electrode placement in implantable cardioverter defibrillator recipients--results of the SPICE (Septal Positioning of ventricular ICD Electrodes) study.

Kolb C, Solzbach U, Biermann J, Semmler V, Kloppe A, Klein N, Lennerz C, Szendey I, Andrikopoulos G, Tzeis S, Asbach S; SPICE-investigators.

Int J Cardiol. 2014 Jul 1;174(3):713-20. doi: 10.1016/j.ijcard.2014.04.229. Epub 2014 Apr 26.

PMID:
24838056
11.

A human ex vivo atherosclerotic plaque model to study lesion biology.

Erbel C, Okuyucu D, Akhavanpoor M, Zhao L, Wangler S, Hakimi M, Doesch A, Dengler TJ, Katus HA, Gleissner CA.

J Vis Exp. 2014 May 6;(87). doi: 10.3791/50542.

12.

Varespladib and cardiovascular events in patients with an acute coronary syndrome: the VISTA-16 randomized clinical trial.

Nicholls SJ, Kastelein JJ, Schwartz GG, Bash D, Rosenson RS, Cavender MA, Brennan DM, Koenig W, Jukema JW, Nambi V, Wright RS, Menon V, Lincoff AM, Nissen SE; VISTA-16 Investigators.

JAMA. 2014 Jan 15;311(3):252-62. doi: 10.1001/jama.2013.282836.

PMID:
24247616
13.

Heart rate reduction for 36 months with ivabradine reduces left ventricular mass in cardiac allograft recipients: a long-term follow-up study.

Doesch AO, Mueller S, Erbel C, Gleissner CA, Frankenstein L, Hardt S, Ruhparwar A, Ehlermann P, Dengler T, Katus HA.

Drug Des Devel Ther. 2013 Nov 5;7:1323-8. doi: 10.2147/DDDT.S53705. eCollection 2013.

14.

Increased adherence eight months after switch from twice daily calcineurin inhibitor based treatment to once daily modified released tacrolimus in heart transplantation.

Doesch AO, Mueller S, Akyol C, Erbel C, Frankenstein L, Ruhparwar A, Ehlermann P, Dengler TJ, Katus HA.

Drug Des Devel Ther. 2013 Oct 21;7:1253-8. doi: 10.2147/DDDT.S52820. eCollection 2013.

15.

A 1-year randomized controlled study of everolimus versus mycophenolate mofetil with reduced-dose cyclosporine in maintenance heart transplant recipients.

Bara C, Dengler T, Hack MA, Ladenburger S, Lehmkuhl HB.

Transplant Proc. 2013 Jul-Aug;45(6):2387-92. doi: 10.1016/j.transproceed.2013.03.032.

PMID:
23953553
16.

Effects of vildagliptin (Galvus®) therapy in patients with type 2 diabetes mellitus after heart transplantation.

Gueler I, Mueller S, Helmschrott M, Oeing CU, Erbel C, Frankenstein L, Gleißner C, Ruhparwar A, Ehlermann P, Dengler TJ, Katus HA, Doesch AO.

Drug Des Devel Ther. 2013 Apr 8;7:297-303. doi: 10.2147/DDDT.S43092. Print 2013.

17.

High-sensitive Troponin T measurements early after heart transplantation predict short- and long-term survival.

Erbel C, Taskin R, Doesch A, Dengler TJ, Wangler S, Akhavanpoor M, Ruhparwar A, Giannitsis E, Katus HA, Gleissner CA.

Transpl Int. 2013 Mar;26(3):267-72. doi: 10.1111/tri.12024. Epub 2012 Dec 17.

18.

Effects of oral valganciclovir prophylaxis for cytomegalovirus infection in heart transplant patients.

Doesch AO, Repp J, Hofmann N, Erbel C, Frankenstein L, Gleissner CA, Schmidt C, Ruhparwar A, Zugck C, Schnitzler P, Ehlermann P, Dengler TJ, Katus HA.

Drug Des Devel Ther. 2012;6:289-95. doi: 10.2147/DDDT.S36578. Epub 2012 Oct 12.

19.

Everolimus is associated with a reduced incidence of cytomegalovirus infection following de novo cardiac transplantation.

Kobashigawa J, Ross H, Bara C, Delgado JF, Dengler T, Lehmkuhl HB, Wang SS, Dong G, Witte S, Junge G, Potena L.

Transpl Infect Dis. 2013 Apr;15(2):150-62. doi: 10.1111/tid.12007. Epub 2012 Sep 26.

PMID:
23013440
20.

Human platelet antigen genotypes in Turkish and Caucasian blood donors in Germany.

Hauck-Dlimi B, Hammon K, Eckstein R, Ott S, Zimmermann R, Dengler T, Ringwald J.

Tissue Antigens. 2012 Sep;80(3):214-8. doi: 10.1111/j.1399-0039.2012.01908.x. Epub 2012 Jun 11.

PMID:
22681418

Supplemental Content

Loading ...
Support Center